Brief: Somalogic Announces Preliminary Full Year 2022 Revenue And Provides Organizational And Strategic Updates
Somalogic Inc SLGC.O :
* SOMALOGIC ANNOUNCES PRELIMINARY FULL YEAR 2022 REVENUE AND
PROVIDES ORGANIZATIONAL AND STRATEGIC UPDATES
* PRELIMINARY, UNAUDITED REVENUE FOR FULL YEAR 2022 IS
EXPECTED TO
BE AT HIGH END OF ITS GUIDANCE RANGE OF $93 TO $98 MILLION
* FY2022 REVENUE VIEW $95.0 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbTKQM7
Further company coverage: SLGC.O
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders